NASDAQ · Medical - Devices

Aethlon Medical, Inc. (AEMD) Stock

$6.10 +1.50% NASDAQ: AEMD Healthcare

Valuation

MetricValue
Price$6.10
Market Cap$3.21M
P/E Ratio-0.55
P/B Ratio0.48
P/S Ratio0.00
EPS (TTM)$-85.80
52-Week High$40.50
52-Week Low$1.41
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-123.09%
ROA-111.26%
ROCE-136.18%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.07
Current Ratio3.00

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$1.0M$0$0$0
Operating Profit$-10.0M$-12.0M$-13.0M$-9.0M$-7.0M
Net Profit$-10.0M$-12.0M$-12.0M$-13.0M$-7.0M
EPS$-564.68$-468.60$-388.67$-85.77$-10.61
Op Margin-3542.5%-2072.1%———

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$19.0M$18.0M$8.0M$7.0M$6.0M
Total Liabilities$2.0M$2.0M$2.0M$2.0M$1.0M
Cash$17.0M$15.0M$5.0M$6.0M$5.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$0

Latest News

Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream GlobeNewswire · Jul 15, 2026 Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® PR Newswire · Jul 13, 2026 Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules PR Newswire · Jul 6, 2026 Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier® PR Newswire · Jun 26, 2026 Aethlon Medical advances Hemopurifier study as final trial cohort nears completion Proactive · Jun 17, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-10.0M$-11.0M$-10.0M$-8.0M$-7.0M
Investing Cash Flow$-1.0M$-2.0M$-1.0M$0$0
Financing Cash Flow$0$0$0$4.0M$0
Net Cash Flow$7.0M$-3.0M$-9.0M$0$0
Free Cash Flow$-10.0M$-11.0M$-10.0M$-8.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.18
FCF Yield-56249.98%
Quick Ratio5.42
Interest Coverage-492.66
Return 1Y-94.27%
Return 3Y-99.80%
Return 5Y-99.98%

Ownership

Insiders Held5.15%
Institutions Held5.82%
Institutions Float Held6.13%
Institutional HolderSharesReport Date
Geode Capital Management, LLC24,3642026-03-31
Ikarian Capital, LLC14,3642026-03-31
Shay Capital LLC14,1242026-03-31
Xtx Topco Ltd13,3422026-03-31
Morgan Stanley2,0472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
CODXCo-Diagnostics, Inc. $1.11 +1.83% -0.04 $6.94M 0.00%
ERNAErnexa Therapeutics Inc. $2.31 -7.23% -0.15 $3.77M 0.00%
IINNInspira Technologies OXY B.H.N. Ltd. $1.26 -5.97% -2.80 $30.34M 0.00%

About Aethlon Medical, Inc.

Aethlon Medical, Inc. is led by CEO James Frakes, employs 14 people, headquartered in US, publicly traded since 1999.

Aethlon Medical, Inc. (AEMD) stock trades at $6.10 with a market capitalization of $3.21M. The stock is valued at a price-to-earnings (P/E) ratio of -0.55, price-to-book of 0.48, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.41 and $40.50, and currently trades 84.9% below its 52-week high.

On profitability, Aethlon Medical, Inc. generates a return on equity (ROE) of -123.09%, return on capital employed of -136.18%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1174.49 +0.42% JNJ Johnson & Johnson $261.01 +1.76% ABBV AbbVie Inc. $277.37 +1.82% MRK Merck & Company, Inc. Common Stock (new) $145.82 +2.42% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.12 +1.93% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.71 +1.19% AMGN Amgen Inc. $415.88 +2.07% GILD Gilead Sciences, Inc. $151.29 +2.85% ABT Abbott Laboratories $99.18 +0.70% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides